Location History:
- Palo Alto, CA (US) (2019 - 2022)
- Taipei, TW (2022)
Company Filing History:
Years Active: 2019-2022
Title: The Innovative Journey of David Chih-Kuang Chou
Introduction: David Chih-Kuang Chou, an accomplished inventor based in Palo Alto, California, has made significant contributions to the field of pharmaceuticals with a portfolio of four innovative patents. His work primarily focuses on developing unique pharmaceutical compositions and formulations that aim to revolutionize treatment options in various medical domains.
Latest Patents: One of Chou's notable inventions is a **pharmaceutical composition comprising thrombolytic peptide-tetrahydroisoquinoline conjugate**. This invention provides a binary conjugate, DC009, which combines a thrombolytic peptide (Pro-Ala-Lys) with a tetrahydroisoquinoline compound. It is designed to have a pH of less than 6.5, ideally ranging from pH 2-5.5, and may include acceptable excipients such as mannitol and sucrose. Another innovative patent by Chou is related to **pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester**. This invention details extended-release injectable formulations that utilize a nalbuphine ester prodrug. These formulations are dissolved in a solution that contains a pharmaceutically acceptable oil, allowing for adjustable duration of action based on the oil-to-solvent ratio.
Career Highlights: Chou has had a significant career in the pharmaceutical industry, where he has applied his expertise in crafting effective medical solutions. Notably, he has worked with prominent companies such as Lumosa Therapeutics and Shanghai Lumosa Therapeutics, contributing his knowledge and innovations to the advancement of therapeutic options.
Collaborations: Throughout his career, David has collaborated with esteemed colleagues, including Chan-Jung Li and Jin-Ding Huang. These collaborations have enriched his work and expanded the impact of his inventions within the pharmaceutical community.
Conclusion: David Chih-Kuang Chou exemplifies the spirit of innovation in the pharmaceutical industry. With a solid foundation of patents and impactful collaborations, his contributions pave the way for future advancements in medical treatments, showcasing the vital role of dedicated inventors in improving healthcare outcomes.